PureHealth Holding PJSC announced its financial results for the first half of 2024, showing significant growth in revenue and earnings. The group’s earnings soared by 15% year-on-year to Dh2.2 billion, while revenues saw a 53% increase to Dh12.5 billion in the same period. This growth is attributed to strong performance across various verticals, particularly in hospitals, insurance, and procurement segments.
Furthermore, the Group reported a net profit of Dh1.0 billion, resulting in a net profit margin of 8.0%. The earnings before interest, taxes, depreciation, and amortization (Ebitda) margin for the Group during this period was 17.2%. Revenue from hospitals experienced an 83% year-on-year growth to Dh9.6 billion, driven by acquisitions and increased patient volumes. The insurance segment also saw a 15% growth in revenues to Dh3.3 billion due to enhanced insurance portfolios and an increase in active members.
In terms of strategic acquisitions, the Group acquired a 100% stake in Circle Health Group and Sheikh Shakhbout Medical City, while divesting its investments in Yas Clinic Group and Abu Dhabi Stem Cell Centre. The Group’s focus remains on advancing specialized healthcare services and streamlining operations to enhance its focus on advancing healthcare services. The Chairman of PureHealth, Hamad Al Hammadi, reaffirmed the company’s commitment to transforming healthcare delivery in the UAE and beyond.
Shaista Asif, the group’s CEO, expressed positivity towards the future, stating that the strong performance in the first half of 2024 positions them well to capitalize on opportunities and create value for shareholders. The Group’s success in the first half of the year is a testament to the trust patients place in their services and their dedication to being a leading healthcare provider in the UAE with global aspirations. As they continue to pursue expansion both locally and internationally, the Group remains focused on delivering growth and value to its stakeholders.
